Home » Biotechnology » Metabolomics Market

Metabolomics Market By Product And Services (Metabolomic Instruments, Metabolomics Bioinformatics Tools And Services), By Application (Biomarker Discovery, Drug Discovery, Functional Genomics, Personalized Medicine, Toxicology Testing, Nutrigenomics), By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors Of Metabolism) – Growth, Future Prospects And Competitive Analysis 2017 – 2025

Price: $4999

Published: | Report ID: 9638 | Report Format : PDF

Market Insights

Metabolomics is a novel, emerging, and dynamic field that studies metabolites and distinctive chemical fingerprints produced during cellular processes. Thus, it identifies and quantifies metabolites further with the help of analytical technologies and the application of bioinformatics, which extract information and analyze the same. Metabolomics, though currently at a nascent stage, will be widely used in the biopharma and biotech industries as a tool for biomarker drug development and information

. Being non-invasive in nature and closely linked to the phenotype, it is an ideal tool used in agricultural industries, pharmaceutical industries, and preventive healthcare. A rise in the number of clinical trials, awareness about nutritional products, toxicological testing data, and the rapid growth of metabolomics data analysis software and solutions are expected to propel the growth of this market.

The report titled “Metabolomics Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall metabolomics market along with the market size and estimates for the duration of 2015–2025. The said research study covers an in-depth analysis of multiple market segments based on the type of product and service, application, indication, and different geographies.

The product and service type segment studied for analyzing the overall global metabolomics market is majorly segmented into metabolomics instruments and metabolomics bioinformatics tools and services. Metabolomics instruments are sub-segmented into separation tools and detection tools. Separation tools include high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography, and capillary electrophoresis.

Detection tools comprise mass spectrometry, nuclear magnetic resonance spectroscopy, and surface-based mass analysis. Metabolomics’ bioinformatics tools and services category is sub-segmented into bioinformatics tools and databases and bioinformatics services.

The global metabolomics market is segmented by application type into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and others. Based on indications, this market is categorized into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others.

Geographically, the global metabolomics market is studied for the following regional markets:

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • France
    • UK.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global metabolomics market.

Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the global metabolomics market’s competitive scenario. This report concludes with a company profiles section that highlights major information about the key players engaged in the global metabolomics market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.

Based on the type of product and service, the global metabolomics market is segmented as follows:

  • Metabolomics Instruments
  • Separation Tools
  • High-Performance Liquid Chromatography
  • Gas Chromatography
  • Ultra-Performance Liquid Chromatography
  • Capillary Electrophoresis
  • Detection Tools
  • Mass Spectrometry
  • Nuclear Magnetic Resonance Spectroscopy
  • Surface-Based Mass Analysis
  • Metabolomics, Bioinformatics, Tools, and Services
  • Bioinformatics Tools and Databases
  • Bioinformatics Services

Metabolomics instruments occupy the largest share of the global metabolomics market. Metabolomics bioinformatics tools and services are a fast-growing segment during the forecast period. With further technological developments, bioinformatics tools have enhanced the untargeted metabolomics workflow, enabling researchers to identify metabolites from LC/MS data and assign their biological roles with respect to chemical pathways.

In the separation tools segment, high-performance liquid chromatography dominates the market. While ultra-performance liquid chromatography offers high efficiency and high-resolution chromatographic separation with reduced analysis time, it is also expected to be a rapidly growing market in the future. In the detection tool segment, mass spectrometry occupies the maximum share, with nuclear magnetic resonance spectroscopy showing fast adaptability and bright future market growth.

Based on the type of application, the global metabolomics market is segmented as follows:

  • Biomarker Discovery
  • Drug Discovery
  • Functional Genomics
  • Personalized Medicine
  • Toxicology Testing
  • Nutrigenomics
  • Others

Biomarker discovery occupies the largest share of the global metabolomics market. Metabolomics techniques aid in the discovery of potential biomarkers and the understanding of the pathogeneses of numerous human diseases.

With advancements in analytical technology, it is possible to quantify the biomarkers from small amounts of specimens using minimally invasive or non-invasive procedures to facilitate high-throughput analysis for real-time application in clinical settings.

The next big market for metabolomics will be drug discovery. Metabolomics helps in diagnosing the disease by understanding the biochemical pathway, thus further aiding in drug identification, design, and customization according to therapeutic needs. Personalized medicine is anticipated to be the fastest-growing segment during the forecast period, with biotech and pharma companies investing heavily in its research and development.

Based on the type of indication, the global metabolomics market is segmented as follows:

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Others

Cancer dominates the global metabolomics market by indication segmentation. Cancer study through metabolomics helps in revealing new biomarkers for cancer, which would help in future diagnosis, prognosis, and therapy. Cardiovascular chronic disease is the greatest public health burden globally.

Thus, the use of metabolomic profiling would help identify new biomarkers and mechanisms of CVD risk. Because a current clinical diagnosis of neurological diseases such as Parkinson’s and Alzheimer’s is inadequate, emerging metabolomics techniques aid in the discovery of biomarkers and biochemical pathways for improving future diagnosis and prognosis therapy.

For the purpose of this study, the global metabolomics market is geographically categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

North America dominates the global metabolomics market, followed by Europe. The key drivers are the surge in research and development funding by government and private players for metabolomics studies, rising demand for personalized medicine and toxicology testing, easy accessibility of technologically advanced products and their high adoption rate, and the presence of various metabolomics manufacturers.

Growing demand for personalized medicine and the large presence of analytical equipment manufacturers in Europe contribute to the growth of the metabolomics market. Asia Pacific has a significant growth opportunity for the metabolomics market due to the presence of a number of pharmaceutical and biotechnology companies and its initiatives in research and development, improving healthcare infrastructure, and emerging economies such as China, Japan, India, and Singapore.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Metabolomics Portraiture
2.2 Global Metabolomics Share, by Product and Service, 2016 (US $ Mn)
2.3 Global Metabolomics, by Type of Application, 2016 (US$ Mn)
2.4 Global Metabolomics, by Type of Indication, 2016 (US$ Mn)
2.5 Global Metabolomics, by Geography, 2016 (Value %)

Chapter 3 Global Metabolomics Analysis
3.1 Global Metabolomics Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition, 2016
3.4 Market Positioning Analysis of Key Players: Metabolomics Market, 2016

Chapter 4 Global Metabolomics Analysis, by Product and Services, 2015-2025 (US$)
4.1 Introduction
4.2 Metabolomic Instruments
4.2.1 Separation Tools
4.2.1.1 Gas Chromatography
4.2.1.2 Ultra-Performance Liquid Chromatography
4.2.1.3 Capillary Electrophoresis
4.2.2 Detection Tools
4.2.2.1 Mass Spectrometry
4.2.2.1 Nuclear Magnetic Resonance Spectroscopy
4.2.2.1 Surface-Based Mass Analysis
4.3 Metabolomics Bioinformatics Tools and Services
4.3.1 Bioinformatics Tools & Databases
4.3.2 Bioinformatics Services

Chapter 5 Metabolomics Analysis, by Application, 2015-2025 (US$)
5.1 Introduction
5.2 Biomarker Discovery
5.3 Drug Discovery
5.4 Functional Genomics
5.5 Personalized Medicine
5.6 Toxicology Testing
5.7 Nutrigenomics
5.8 Others

Chapter 6 Metabolomics Analysis, by Indication, 2015-2025 (US$)
6.1 Introduction
6.2 Cancer
6.3 Cardiovascular Disorders
6.4 Neurological Disorders
6.5 Inborn Errors of Metabolism
6.6 Others

Chapter 7 Global Metabolomics, By Geography
7.1 Preface
7.2 North America (U.S. & Canada)
7.3 Europe (U.K., Germany & Rest of Europe)
7.4 Asia Pacific (China, Japan, and Rest of APAC)
7.5 Latin America (Brazil, Mexico and Rest of LATAM)
7.6 Middle East and Africa

Chapter 8 Company Profiles
8.1 Agilent Technologies, Inc.
8.2 Acureomics AB
8.3 Amatsi Group
8.4 Bayer, Inc.
8.5 Berg LLC
8.6 Biocrates Life Sciences AG
8.7 Bio-Rad Laboratories, Inc.
8.8 Bruker Corporation
8.9 Chenomx,Inc
8.10 Danher Corporation
8.11 Human Metabolome Technologies, Inc.
8.12 HepatoChem, Inc.
8.13 IROA Technologies
8.14 Leco Corporation
8.15 Metabolon, Inc.
8.16 Max Planck Society
8.17 Metabolomic Discoveries GmbH
8.18 Metabolomx
8.19 Metabometrix Ltd.
8.20 Metanomics GmbH
8.21 Phenomenome Discoveries, Inc.
8.22 SCIEX
8.23 Shimadzu Corporation
8.24 SiDMAP
8.25 Stemina Biomarker Discovery, Inc
8.26 Thermo Fisher Scientific, Inc.
8.27 Waters Corporation
8.28 Xceleron, Inc.
8.29 Other Notable Players

List of Figures

FIG. 1 Global Metabolomics: Research Methodology
FIG. 2 Global Metabolomics Share, by Product and Service, 2016 (US$ Mn)
FIG. 3 Global Metabolomics, by Type of Application, 2016 (US$ Mn)
FIG. 4 Global Metabolomics, by Type of Indication, 2016 (US$ Mn)
FIG. 5 Global Metabolomics, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition: Global Metabolomics, by Geography
FIG. 7 Competitive Analysis: Key Players in Global Metabolomics
FIG. 8 Global Metabolomics Gas Chromatography Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Metabolomics Ultra-Performance Liquid Chromatography Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Metabolomics Capillary Electrophoresis Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Metabolomics Mass Spectrometry Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Metabolomics Nuclear Magnetic Resonance Spectroscopy Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Metabolomics Surface-Based Mass Analysis Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Metabolomics Bioinformatics Tools & Databases Market, 2015 – 2025 (US$ Mn)
FIG. 15 Global Metabolomics Bioinformatics Services Market, 2015 – 2025 (US$ Mn)
FIG. 16 Global Biomarker Discovery Market , 2015 – 2025 (US$ Mn)
FIG. 17 Global Drug Discovery Market, 2015 – 2025 (US$ Mn)
FIG. 18 Global Functional Genomics Market, 2014 – 2024 (US$ Mn)
FIG. 19 Global Personalized Medicine Market, 2015 – 2025 (US$ Mn)
FIG. 20 Global Toxicology Testing Market, 2015 – 2025 (US$ Mn)
FIG. 21 Global Nutrigenomics Market, 2015 – 2025 (US$ Mn)
FIG. 22 Global Other Application Market, 2015 – 2025 (US$ Mn)
FIG. 23 Global Metabolomics Market, By Cancer Application , 2015 – 2025 (US$ Mn)
FIG. 24 Global Metabolomics Market, By Cardiovascular Disorders Application, 2015 – 2025 (US$ Mn)
FIG. 25 Global Metabolomics Market, By Neurological Disorder Application Market, 2015 – 2025 (US$ Mn)
FIG. 26 Global Metabolomics Market, By Inborn Errors of Metabolism Application, 2015 – 2025 (US$ Mn)
FIG. 27 Global Metabolomics Market, By Other Application Market, 2015 – 2025 (US$ Mn)
FIG. 28 Latin America Metabolomics, 2015 – 2025 (US$ Mn)
FIG. 29 Middle East & Africa Metabolomics, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Metabolomics, By Product and Services, 2015-2025 (US$ Mn)
TABLE 2 Global Metabolomics Instruments Market, 2015-2025 (US$ Mn)
TABLE 3 Global Metabolomics Separation Tools Market, 2015-2025 (US$ Mn)
TABLE 4 Global Metabolomics Detection Tools Market, 2015-2025 (US$ Mn)
TABLE 5 Metabolomics, by Application Type , 2015-2025 (US$ Mn)
TABLE 6 Metabolomics, by Application Type , 2015-2025 (US$ Mn)
TABLE 7 Global Metabolomics, by Geography, 2015 – 2025 (US$ Mn)
TABLE 8 North America Metabolomics, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Metabolomics, by Country, 2015 – 2025 (USD Mn)
TABLE 10 Asia-Pacific Metabolomics, by Country, 2015 – 2025 (USD Mn)
TABLE 11 Agilent Technologies, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 12 Acureomics AB: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 13 Amatsi Group: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 14 Bayer, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position Portfolio; News Coverage)
TABLE 15 Berg LLC: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 16 Biocrates Life Sciences AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 17 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 18 Bruker Corporation: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 19 Chenomx,Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 20 Danher Corporation: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 21 Human Metabolome Technologies, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 22 HepatoChem, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 23 IROA Technologies: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 24 Leco Corporation: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 25 Metabolon, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 26 Max Planck Society: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 27 Metabolomic Discoveries GmbH: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 28 Metabolomx: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 29 H Metabometrix Ltd.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 30 Metanomics GmbH: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 31 Phenomenome Discoveries, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 32 SCIEX: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 33 Shimadzu Corporation: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 34 SiDMAP: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 35 Stemina Biomarker Discovery, Inc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 36 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 37 Waters Corporation: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 38 Xceleron, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)

Frequently Asked Question

What is the size of Metabolomics Market?

The market for Metabolomics Market is expected to reach USD$ 2,428.1 Mn in 2025.

What is the Metabolomics Market CAGR?

The Metabolomics Market is expected to see significant CAGR growth over the coming years, at 15.3%.

What is the Forecast period considered for Metabolomics Market?

The report is forecasted from 2017 -2025.

What is the base year considered for Metabolomics Market?

The base year of this report is 2016.

Who are the major players in this market?

Agilent Technologies, Inc., Acureomics AB,Amatsi Group,Bayer, Inc.,Berg LLC.are of the major players in the global market.

Digital PCR Market

Published:
Report ID: 12323

In-Vitro ADME Services Market

Published:
Report ID: 11191

Europe Distributed Solar Power Generation Market

Published:
Report ID: 37132

Biotechnology Contract Manufacturing Market

Published:
Report ID: 36713

Cell Culture Media And Reagents Market

Published:
Report ID: 3489

Viral Antigens Market

Published:
Report ID: 36114

Recombinant Protein Market

Published:
Report ID: 35991

Bacteriophage Market

Published:
Report ID: 2114

India Bone Marrow Transplantation (BMT) Market

Published:
Report ID: 35571

Bioengineered Skin And Skin Substitutes Market

Published:
Report ID: 3472

DNA and RNA Sample Preparation Market

Published:
Report ID: 34911

Laboratory Filtration Market

Published:
Report ID: 7940

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN